| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048816071 |
| P356 | DOI | 10.1016/S1071-3581(99)90064-8 |
| P8608 | Fatcat ID | release_ejt4a75ex5dobm3flbiuy2txda |
| P698 | PubMed publication ID | 10070840 |
| P2093 | author name string | Palinski W | |
| Tsimikas S | |||
| Witztum JL | |||
| Curtiss LK | |||
| Halpern SE | |||
| Yeung DW | |||
| P2860 | cites work | Detection of experimental atherosclerosis with indium-111 radiolabelled hematoporphyrin derivative | Q28342160 |
| Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man | Q28359675 | ||
| Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
| Role of oxidised low density lipoprotein in atherogenesis | Q33613205 | ||
| Low density lipoprotein undergoes oxidative modification in vivo | Q33838672 | ||
| Compensatory enlargement of human atherosclerotic coronary arteries | Q34184275 | ||
| Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis | Q34737721 | ||
| Assessment of stenoses in coronary angioplasty. Inter- and intraobserver variability | Q72787902 | ||
| Evaluation of indium-111-polyclonal immunoglobulin G to quantitate atherosclerosis in Watanabe heritable hyperlipidemic rabbits with scintigraphy: effect of age and treatment with antioxidants or ethinylestradiol | Q72817974 | ||
| Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. | Q35817369 | ||
| Monoclonal antibody pretargetting techniques for tumour localization: the avidin-biotin system. International Workshop on Techniques for Amplification of Tumour Targetting | Q37198993 | ||
| Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma | Q37358413 | ||
| Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein | Q37358421 | ||
| Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins | Q38295835 | ||
| Coronary artery screening by electron beam computed tomography. Facts, controversy, and future. | Q40459822 | ||
| Molecular bases of the acute coronary syndromes | Q40530238 | ||
| Addition of sulfhydryl groups of Escherichia coli ribosomes by protein modification with 2-iminothiolane (methyl 4-mercaptobutyrimidate) | Q40975811 | ||
| Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? | Q41263009 | ||
| Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments | Q41318509 | ||
| Rapid blood clearance of biotinylated IgG after infusion of avidin | Q43494548 | ||
| In vivo technetium-99m S12 antibody imaging of platelet alpha-granules in rabbit endothelial neointimal proliferation after angioplasty | Q43651037 | ||
| Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits | Q43652291 | ||
| Permeability of arterial endothelium to plasma macromolecules. The concomitant transfer of plasma phosphatidylethanolamine, phosphatidylcholine, sphingomyelin and phosphoprotein across the aortic endothelial surface in normal cockerels following the | Q43702509 | ||
| Chemical evaluation of conformational differences in native and chemically modified proteins | Q43724712 | ||
| Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe | Q44074481 | ||
| Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistribution | Q44709603 | ||
| Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits | Q44853175 | ||
| Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits | Q45252141 | ||
| ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. | Q45995512 | ||
| Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. | Q46030815 | ||
| Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. | Q46150836 | ||
| Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits | Q46491747 | ||
| Magnetic resonance imaging to study lesions of atherosclerosis in the hyperlipidemic rabbit aorta. | Q51029606 | ||
| External imaging of atherosclerosis in rabbits using an 123I-labeled synthetic peptide fragment. | Q52884716 | ||
| Atherosclerotic plaque caps are locally weakened when macrophages density is increased | Q67945371 | ||
| Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins | Q67967623 | ||
| Impact of compensatory enlargement of atherosclerotic coronary arteries on angiographic assessment of coronary artery disease | Q69405227 | ||
| Radionuclide imaging of experimental atherosclerosis with nonspecific polyclonal immunoglobulin G | Q69640648 | ||
| Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits | Q69743359 | ||
| Indium-111-labeled platelet scintigraphy in carotid atherosclerosis | Q69937929 | ||
| Dissociation of [3H]cholesterol and 125I-labelled plasma protein influx in normal and atheromatous rabbit aorta. A quantitative histochemical study | Q70094245 | ||
| Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products | Q70328162 | ||
| Biodistribution and radioimmunopharmacokinetics of 131I-Ama monoclonal antibody in atherosclerotic rabbits | Q70820763 | ||
| Scintigraphic detection of carotid atherosclerosis with indium-111-labeled autologous platelets | Q71156381 | ||
| Evidence for more extensive deposits of epitopes of oxidized low density lipoprotein in aortas of young people with elevated serum thiocyanate levels. PDAY Research Group | Q71183996 | ||
| Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? | Q71280475 | ||
| Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death | Q71306624 | ||
| Functional and anatomic evaluation of carotid atherothrombosis. A combined study of indium 111 platelet scintigraphy and B-mode ultrasonography | Q71563406 | ||
| External imaging of human atherosclerosis | Q71654902 | ||
| Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis | Q71799126 | ||
| Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture | Q72034135 | ||
| Renal and Systemic Transvascular Albumin Leakage in Severe Atherosclerosis | Q72049333 | ||
| Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a) | Q72100957 | ||
| Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group | Q72200868 | ||
| Early change of vascular permeability in hypercholesterolemic rabbits | Q72235776 | ||
| Distribution of plasma proteins across the human aortic wall Barrier functions of endothelium and internal elastic lamina | Q72626406 | ||
| Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology | Q72708405 | ||
| P433 | issue | 1 Pt 1 | |
| P921 | main subject | antibody | Q79460 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 41-53 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Journal of Nuclear Cardiology | Q609415 |
| P1476 | title | Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo | |
| P478 | volume | 6 |
| Q36261207 | Antibodies for molecular imaging in the cardiovascular system |
| Q86779027 | Atheroma and the inflammasome |
| Q36390068 | Atherosclerosis imaging on the molecular level |
| Q35013001 | Atherosclerosis imaging to detect and monitor cardiovascular risk |
| Q31880890 | Circulating antibodies recognizing malondialdehyde-modified proteins in healthy subjects. |
| Q36387263 | Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions |
| Q35169184 | Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444. |
| Q79438471 | Fluorodeoxyglucose and calcium uptake in the vascular wall: clinically relevant or sugar-coated pill? |
| Q28389691 | Generation and biological activities of oxidized phospholipids |
| Q56986839 | Identification of interleukin-2 for imaging atherosclerotic inflammation |
| Q34477436 | Imaging of Oxidation-Specific Epitopes in Atherosclerosis and Macrophage-Rich Vulnerable Plaques |
| Q34518372 | Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions |
| Q35905632 | In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes |
| Q36681348 | Initiation and progression of atherosclerosis--enzymatic or oxidative modification of low-density lipoprotein? |
| Q34580898 | Localization of oxidized low-density lipoprotein and its relation to plaque morphology in human coronary artery |
| Q34161103 | Manganese G8 dendrimers targeted to oxidation-specific epitopes: in vivo MR imaging of atherosclerosis |
| Q52694389 | Molecular Imaging in Drug Discovery and Development. |
| Q30484224 | Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation |
| Q30478541 | Molecular imaging in atherosclerosis. |
| Q30442045 | Molecular imaging in cardiovascular disease: Which methods, which diseases? |
| Q30485880 | Molecular imaging of activated matrix metalloproteinases in vascular remodeling |
| Q30492960 | Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease |
| Q50708993 | Molecular imaging of vascular cell adhesion molecule-1 expression in experimental atherosclerotic plaques with radiolabelled B2702-p. |
| Q40361537 | Molecular imaging of vulnerable atherosclerotic plaques |
| Q37177648 | Molecular imaging will replace perfusion imaging: The impossible dream |
| Q35936423 | Molecular, cellular and functional imaging of atherothrombosis |
| Q38089761 | Nanotechnology in the diagnosis of atherosclerotic disease |
| Q34140725 | New developments in the detection of vulnerable plaque |
| Q34628693 | Non-invasive imaging of plaque vulnerability: an important tool for the assessment of agents to stabilise atherosclerotic plaques |
| Q45965485 | Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies. |
| Q26781838 | Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques |
| Q36385153 | Oxidized low-density lipoprotein biomarkers in atherosclerosis |
| Q49955253 | PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis |
| Q37438144 | Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview |
| Q34912643 | Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT |
| Q37196226 | Radionuclide imaging: a molecular key to the atherosclerotic plaque |
| Q26787117 | Recent Advances of Radionuclide-Based Molecular Imaging of Atherosclerosis |
| Q54518833 | Relationship between oxidized LDL, IgM, and IgG autoantibodies to ox-LDL levels with recurrent cardiovascular events in Swedish patients with previous myocardial infarction. |
| Q74592557 | Strategic targeting of atherosclerotic lesions |
| Q37787083 | Target: ligand interactions of the vascular endothelium. Implications for molecular imaging in inflammation |
| Q34982799 | Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes. |
| Q41370572 | Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes |
| Q36090166 | Targeting the vulnerable plaque: the evolving role of nuclear imaging |
| Q36304170 | Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging |
| Q46105858 | Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes |
| Q46535633 | The atherosclerotic plaque: a healthy challenge to the limits of nuclear imaging |
| Q34214486 | The endothelium: dysfunction and beyond |
| Q36496252 | The pathobiology of the vessel wall: implications for imaging |
| Q38187881 | Visualizing the atherosclerotic plaque: a chemical perspective |
Search more.